AstraZeneca to sell Chinese-developed cancer drug in the US
⏮ BeforeThe FDA-approved cancer drug was unavailable in the US, and desperate patients travelled to China to get it.
✅ NowAstraZeneca says it will start selling the drug in the US.
In short
- The drug was approved by the US Food and Drug Administration but was not sold in the US.
- Some Americans travelled to Shanghai to buy the medicine.
- The source text is cut off, so the timing and price are not confirmed here.
Why the Good News Desk likes this one
The drug was approved by US regulators but was unavailable domestically for a long period. Patients who could afford the trip were buying it in China. Availability in the US would open access to people who cannot travel.
Advertisement
From South China Morning Post
Global pharmaceutical firm AstraZeneca on Thursday said it would start selling a cancer drug after coming under criticism for failing to bring it to the US market faster, prompting some Americans to fly to Shanghai to procure the potentially life-saving medicine first developed by China. In recent months, desperate Americans have travelled to China to obtain the Chinese-made cancer drug that was approved by the US Food and Drug Administration but remained unavailable in the country for more than...
Ask this story
More like this
Advertisement